Vazegepant hydrochloride
Cat. No.：YN322252
CAS No. ：1414976-20-7
| 产品名称: | Vazegepant hydrochloride |
| CAS No.: | 1414976-20-7 |
| Chemical Name: | |
| Synonyms: | Zavegepant hydrochloride; BHV-3500 hydrochloride |
| 分子量: | 675.26 |
| 分子式: | C36H47ClN8O3 |
| SMILES: | Cl[H].O=C([C@@]([H])(C([H])([H])C1=C([H])C2C([H])=NN([H])C=2C(C([H])([H])[H])=C1[H])N([H])C(N1C([H])([H])C([H])([H])C([H])(C2C(N([H])C3=C([H])C([H])=C([H])C([H])=C3C=2[H])=O)C([H])([H])C1([H])[H])=O)N1C([H])([H])C([H])([H])N(C([H])([H])C1([H])[H])C1([H])C |
| 存储: | Please store the product under the recommended conditions in theCertificate of Analysis. |
| 运输: | Room temperature in continental US; may vary elsewhere. |
| 产品描述: | Vazegepant (BHV-3500) hydrochloride 是一种高度亲和性CGRP受体拮抗剂 (hCGRPKi=0.023 nM)。Vazegepant hydrochloride 是第一种用于偏头痛的鼻用 gepant。Vazegepant hydrochloride 可能有助于有效管理 COVID-19 相关肺部炎症。 |
| IC50和靶点: | |
| In Vitro: | |
| In Vivo: | |
| Clinical Trial: | |
| Solvent & Solubility: |
